PortfoliosLab logoPortfoliosLab logo

PSIL Top Holdings & Constituents

PSIL, offered by AdvisorShares, holds 29 reported positions across $44.4M in assets. Its largest holdings are Relmada Therapeutics Inc. (RLMD) (10.17%), ATAIBECKLEY INC (ATAI) (9.92%), and DEFINIUM THERAPEUTICS INC (DFTX) (8.52%). The 5 biggest positions account for 43.25% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.


PositionWeightMarket Value
RLMD
Relmada Therapeutics Inc.
10.17%
$2.06M
ATAI
ATAIBECKLEY INC
9.92%
$2.01M
DFTX
DEFINIUM THERAPEUTICS INC
8.52%
$1.73M
DSVXX
DREY INST PREF GOV MM-M
7.89%
$1.60M
CMPS
Compass Pathways plc
6.74%
$1.36M

Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Mar 31, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.